Search results

This notice was published on August 16, 2022.

Tocilizumab (162 mg/0.9 ml (4 ml)), Tocilizumab (162 mg/0.9 ml (10 ml)) et Tocilizumab (162 mg/0.9 ml (20 ml)) remplace:

• Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (syr)
• Actemra (162 mg/0.9 ml) – S.C. Inj. Sol (pen)

This notice was published on January 19, 2023.

Rifampin 150 mg et 300 mg replace:

• Rofact 150
• Rofact 300

This notice was published on April 5, 2023.

Quinapril hydrochloride 5 mg, 10 mg, 20 mg et 40 mg replace:

• Accupril
• Apo-Quinapril
• pms-Quinapril